-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Swiss researchers have developed a new way to determine the molecular structure of drugs using artificial intelligence technology, which is much more efficient than existing methods and helps the pharmaceutical industry develop new drugs.
to fully understand the efficacy of the drug in the human body, researchers need to determine its molecular structure. Scientists often use MRI to detect molecular structures, but previous calculations have been complex and time-consuming.
in a paper published in the new issue of the British journal Nature Communications, researchers at the Federal Institute of Technology in Lausanne, Switzerland, say they have developed a machine learning program that, after training them using a database, is so efficient at analyzing data from MRI that it is almost 10,000 times more efficient than existing methods.
artificial intelligence technology could help the pharmaceutical industry test drug safety and develop new drugs, and interested parties could use the program for free on the team's website, the researchers said. (Xinhua News Agency)